"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human
- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
Breast Cancer: Risk Assessment, Screening, and Primary Prevention. Med Clin North Am. 2023 Mar; 107(2):271-284.
A metabolome-wide case-control study of african american breast cancer patients. BMC Cancer. 2023 Feb 23; 23(1):183.
The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions. Sci Rep. 2023 Feb 18; 13(1):2880.
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial. Clin Cancer Res. 2023 02 16; 29(4):784-790.
Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer. Int J Gynecol Cancer. 2023 02 06; 33(2):250-256.
De-Escalating Breast Cancer Therapy. Surg Clin North Am. 2023 Feb; 103(1):83-92.
A Competition, Benchmark, Code, and Data for Using Artificial Intelligence to Detect Lesions in Digital Breast Tomosynthesis. JAMA Netw Open. 2023 02 01; 6(2):e230524.
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Med. 2023 01 26; 15(1):7.
Lack of Association of C677T Methylenetetrahydrofolate Reductase Polymorphism with Breast Cancer Risk in Mali. Genet Res (Camb). 2023; 2023:4683831.
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer. Nat Commun. 2023 01 12; 14(1):183.